Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
Status:
Completed
Trial end date:
2013-01-23
Target enrollment:
Participant gender:
Summary
This study aims to assess how glimepiride affects the recovery from hypoglycemia in
participants with type 2 diabetes mellitus. The primary objective is to estimate the time
taken by participants to recover from hypoglycemia to euglycemia after treatment with either
2 mg or 4 mg of glimepiride when compared to placebo.